|
|
Post by tinkusr8215 on Apr 12, 2018 18:58:11 GMT -5
Any one keep tab of the total outstanding shares?..
WSJ reports 123 mil and I am sure that doesnt include latest offering and not sure if it includes the debt payments paid by equity.
From the latest 10K in Feb :
As of February 9, 2018, there were 120,467,137 shares of the registrant’s Common Stock outstanding
|
|
|
|
Post by cjm18 on Apr 12, 2018 19:52:55 GMT -5
Any one keep tab of the total outstanding shares?.. WSJ reports 123 mil and I am sure that doesnt include latest offering and not sure if it includes the debt payments paid by equity. From the latest 10K in Feb : As of February 9, 2018, there were 120,467,137 shares of the registrant’s Common Stock outstanding [br I saw 126m somewhere. Add 14m. 140m. Yuck. Or divide market cap by the price. |
|
|
|
Post by brotherm1 on Apr 12, 2018 21:23:00 GMT -5
I’d like to see a line graph chart of our market cap over the past two years since we kicked SNY out of the deal. Anyone have one to share?
I suppose it might also be interesting to see a secondary line on the chart of shares outstanding.
May as well chart the share price.
I don’t have time to do it.
|
|
|
|
Post by dreamboatcruise on Apr 12, 2018 21:39:18 GMT -5
If one considers all the warrants, debt conversion rights, employee stock option plan, etc., the number of shares obligated is now about 180M if my previous calculations were correct. I might have even missed some, so it could be higher. brotherm1... I can't plot it out over time but I believe the total float at the time of IPO was about 40 million shares. So adjusting for RS that is 8 million in today's shares. So the dilution has taken us from 8M to 180M. Some seem to believe that a share price target that seemed reasonable at the time of IPO should still be today, but obviously that is not logical. |
|
|
|
Post by sportsrancho on Apr 12, 2018 22:00:59 GMT -5
Our high ( IPO ) was $100 let’s go for $40:-)
|
|
|
|
Post by cjm18 on Apr 12, 2018 22:07:06 GMT -5
|
|
|
|
Post by brotherm1 on Apr 12, 2018 22:29:16 GMT -5
interesting. the ole double shoulder, head, limp 1/2 shoulder
|
|
|
|
Post by brotherm1 on Apr 12, 2018 22:52:16 GMT -5
And Afrezza now has more validity than ever before, MNKD has better management than ever before, MNKD owns all of Afrezza now, Trepostinil on board, CGM’s are now less cumbersome and more affordable than ever before, we are moving laterally into other countries, only 2% of the US applicable population is even aware Afrezza exists, tons of shorts to cover, and our market cap is extraordinary low. We could pop back up big any time now.
|
|
|
|
Post by dreamboatcruise on Apr 12, 2018 23:58:24 GMT -5
Our high ( IPO ) was $100 let’s go for $40:-) Might as well just go for $100. |
|
|
|
Post by matt on Apr 13, 2018 9:24:28 GMT -5
Any one keep tab of the total outstanding shares?.. WSJ reports 123 mil and I am sure that doesnt include latest offering and not sure if it includes the debt payments paid by equity. WSJ, Yahoo, Google and other news sites buy their numbers, frequently from Standard & Poors. The numbers reflect what is in SEC filings, but not everything triggers a filing and they only count what is actually issued. A company could have lots of deep in the money warrants that are nearly certain to convert to shares, but until that happens they fall out of the statistics. Similarly, if MNKD is selling shares under the ATM then those will only get reported once per quarter. Your best bet is to wait for the 10-Q. The number of shares outstanding is always on the first page of any 10-Q or 10-K near the bottom. That figure is no more than four days old so it is almost always the best indicator. Starting from that, you have to troll through the footnotes and figure out how many warrants and convertible securities there are and at which prices they are likely to convert. Deerfield, for example, has the option to exchange debt for shares but they are unlikely to do so at today price ($1.65 as I write this). Similarly, the warrants on the last deal will not be exercised unless the price goes back over $2.38 and, as mentioned, the ATM has already been disclosed but the number of shares issued under Rule 415 offerings are only updated quarterly. That answer may not be helpful, but it is the answer. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 13, 2018 11:23:34 GMT -5
matt When stock options are issued, does that number of potential shares go under issued or outstanding?
|
|
|
|
Post by digger on Apr 13, 2018 21:41:38 GMT -5
matt When stock options are issued, does that number of potential shares go under issued or outstanding? What I understand is that they don't go under outstanding, but they still count when figuring up the number of authorized shares left available to sell since they have to keep those shares available should the options be exercised. |
|
|
|
Post by sf1981 on Apr 14, 2018 2:11:15 GMT -5
Any one keep tab of the total outstanding shares?.. WSJ reports 123 mil and I am sure that doesnt include latest offering and not sure if it includes the debt payments paid by equity. From the latest 10K in Feb : As of February 9, 2018, there were 120,467,137 shares of the registrant’s Common Stock outstanding Fully diluted with all warrants we are approaching 170m including the Mann Group at USD 4. Let’s not delude ourselves that there will be no more dilution. I am calculating with 200m by year end. However, that leaves only little debt. If Afrezza sells 100m in two years, that could still be worth USD 1-2bn now. Makes 5-10 bucks per share. The “target price 40” people are crazy. |
|
|
|
Post by boca1girl on Apr 14, 2018 6:47:09 GMT -5
Any one keep tab of the total outstanding shares?.. WSJ reports 123 mil and I am sure that doesnt include latest offering and not sure if it includes the debt payments paid by equity. From the latest 10K in Feb : As of February 9, 2018, there were 120,467,137 shares of the registrant’s Common Stock outstanding Fully diluted with all warrants we are approaching 170m including the Mann Group at USD 4. Let’s not delude ourselves that there will be no more dilution. I am calculating with 200m by year end. However, that leaves only little debt. If Afrezza sells 100m in two years, that could still be worth USD 1-2bn now. Makes 5-10 bucks per share. The “target price 40” people are crazy. I agree that there will be more dilution this year and also agree 1-2B valuation now. I also believe we can get to $40, just not as soon as some believe. 2022 seems more reasonable for a $40 price target. |
|
|
|
Post by sportsrancho on Apr 14, 2018 8:19:41 GMT -5
Fully diluted with all warrants we are approaching 170m including the Mann Group at USD 4. Let’s not delude ourselves that there will be no more dilution. I am calculating with 200m by year end. However, that leaves only little debt. If Afrezza sells 100m in two years, that could still be worth USD 1-2bn now. Makes 5-10 bucks per share. The “target price 40” people are crazy. I agree that there will be more dilution this year and also agree 1-2B valuation now. I also believe we can get to $40, just not as soon as some believe. 2022 seems more reasonable for a $40 price target. My personal target is $25 in 2020. Since I know someone with a $6 target, and someone else with a $300 one, I’d say we’re in the same ballpark:-) |
|
